RenovoRx RNXT
NASDAQ RNXT
$1.22 +0.04 (+3.39%)
At close: Nov 11, 2026 · 4:00 PM EST

RenovoRx (RNXT) Return on Sales [ROS] (2021 - 2026)

Updated

RenovoRx (RNXT) recorded Return on Sales [ROS] of -368.43% in Q2 2026, up 266.17 percentage points from -634.60% a year earlier and up 247.74 percentage points from the prior quarter.

Analysis

RenovoRx (RNXT) Return on Sales [ROS] (2021 - 2026) Analysis & Trends

On a TTM basis, RenovoRx's Return on Sales [ROS] came in at -685.22% as of Jun 30, 2026, up 673.23 percentage points year-over-year; for FY2025, it came in at -1113.98%, up 24397.65 percentage points from FY2024.

  • Annual Return on Sales [ROS] has a three-year change of +16342.16 percentage points (FY2022 to FY2025).
  • Across earlier years, Return on Sales [ROS] came in at -25511.63% in FY2024 (-14959.78 pp), -10551.85% in FY2023 (+6904.29 pp) and -17456.14% in FY2022.
  • The Q2 2026 figure is the highest quarterly Return on Sales [ROS] since Q4 2021.
  • On a year-over-year basis, Return on Sales [ROS] has increased for ten consecutive quarters, with an average year-over-year change of +3539.35 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 218975.00 percentage points in Q1 2023, against a drop of 15230.13 percentage points in Q4 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at -616.16% (Q1 2026), -1479.83% (Q4 2025) and -1203.01% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn 18.65%
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn 10.44%
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn 19.00%
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn 19.44%
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn 18.08%
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn 15.86%
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn 16.12%
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn 17.44%
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn 6.36%
10 RenovoRx 56.86 Mn 17.54 Mn 878,000.00 -303.56%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -303.56%
Jun 30, 2026 -368.43%
Mar 31, 2026 -616.16%
Dec 31, 2025 -1,479.83%
Sep 30, 2025 -1,203.01%
Jun 30, 2025 -634.60%
Mar 31, 2025 -1,578.68%
Dec 31, 2024 -3,096.47%
Sep 30, 2024 -2,280.65%
Jun 30, 2024 -2,198.55%
Mar 31, 2024 -6,691.89%
Dec 31, 2023 -16,154.55%
Sep 30, 2023 -203.76%
Jun 30, 2023 -141.99%
Mar 31, 2023 -100.00%
Dec 31, 2022 -15,500.00%
Sep 30, 2022 -100.14%
Jun 30, 2022 -100.00%
Mar 31, 2022 -100.03%
Dec 31, 2021 -269.87%
API Access

RenovoRx Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=RNXT&period=max&api_key=YOUR_API_KEY